Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Helfrich

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Current Opinion in Molecular Therapeutics|March 16, 2001
Bi-specific antibody therapy for the treatment of cancerS Withoff, W Helfrich, L F de Leij, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1994
Detection of a putative 30-kDa ligand of the cluster-2 antigenW Helfrich, M Van Geel, T H The, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1994
Epitope mapping of SCLC-cluster-2 MAbs and generation of antibodies directed against new EGP-2 epitopesW Helfrich, P W Koning, T H The, et al.
Biochimica Et Biophysica Acta|February 28, 1992
A discordance between the human muscle NCAM sequence and those seen in other NCAM cDNA clonesR J Rossell, A Malik, W Helfrich, et al.
Current Drug Targets|December 19, 2009
Targeted elimination of leukemia stem cells; a new therapeutic approach in hemato-oncologyB ten Cate, M de Bruyn, Y Wei, et al.
Molecular Imaging and Biology|May 23, 2014
Targeted radionuclide and fluorescence dual-modality imaging of cancer: preclinical advances and clinical translationS Lütje, M Rijpkema, W Helfrich, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 21, 2000
The use of bispecific antibodies in tumor cell and tumor vasculature directed immunotherapyG Molema, B J Kroesen, W Helfrich, et al.
Kidney International|March 21, 2008
Systemic gene therapy with interleukin-13 attenuates renal ischemia-reperfusion injuryM Sandovici, R H Henning, H van Goor, et al.
Cytometry|May 15, 1998
Analysis of in vitro lymphocyte adhesion and transendothelial migration by fluorescent-beads-based flow cytometric cell countingG Molema, G Mesander, B J Kroesen, et al.
British Journal of Cancer|March 1, 1996
The role of apoptosis in bispecific antibody-mediated T-cell cytotoxicityB J Kroesen, G J Wellenberg, A Bakker, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Current Opinion in Molecular Therapeutics|March 16, 2001
Bi-specific antibody therapy for the treatment of cancerS Withoff, W Helfrich, L F de Leij, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1994
Detection of a putative 30-kDa ligand of the cluster-2 antigenW Helfrich, M Van Geel, T H The, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1994
Epitope mapping of SCLC-cluster-2 MAbs and generation of antibodies directed against new EGP-2 epitopesW Helfrich, P W Koning, T H The, et al.
Biochimica Et Biophysica Acta|February 28, 1992
A discordance between the human muscle NCAM sequence and those seen in other NCAM cDNA clonesR J Rossell, A Malik, W Helfrich, et al.
Current Drug Targets|December 19, 2009
Targeted elimination of leukemia stem cells; a new therapeutic approach in hemato-oncologyB ten Cate, M de Bruyn, Y Wei, et al.
Molecular Imaging and Biology|May 23, 2014
Targeted radionuclide and fluorescence dual-modality imaging of cancer: preclinical advances and clinical translationS Lütje, M Rijpkema, W Helfrich, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 21, 2000
The use of bispecific antibodies in tumor cell and tumor vasculature directed immunotherapyG Molema, B J Kroesen, W Helfrich, et al.
Kidney International|March 21, 2008
Systemic gene therapy with interleukin-13 attenuates renal ischemia-reperfusion injuryM Sandovici, R H Henning, H van Goor, et al.
Cytometry|May 15, 1998
Analysis of in vitro lymphocyte adhesion and transendothelial migration by fluorescent-beads-based flow cytometric cell countingG Molema, G Mesander, B J Kroesen, et al.
British Journal of Cancer|March 1, 1996
The role of apoptosis in bispecific antibody-mediated T-cell cytotoxicityB J Kroesen, G J Wellenberg, A Bakker, et al.
Pageof 5